CURB
发表于 2025-3-25 03:30:07
https://doi.org/10.1007/978-3-319-11161-2Body Mass Index; Cardiovascular Risk; Dyslipidemia; Hypercholesterolemia; Hyperlipidemia; Lipidology; Lipi
很是迷惑
发表于 2025-3-25 11:33:35
Hussein YassinePractical in design with easy to read, bullet pointed chapters.Comprehensive overview of state of lipid management.Includes abundant algorithms and tables.Includes supplementary material:
偏见
发表于 2025-3-25 14:40:05
http://reply.papertrans.cn/59/5869/586842/586842_23.png
conquer
发表于 2025-3-25 16:21:31
978-3-319-11160-5Springer International Publishing Switzerland 2015
Notify
发表于 2025-3-25 21:39:35
Genetics of Lipid Disorders,iovascular disease (CVD). In this chapter we review the most common genetic disorders of lipid metabolism summarizing the genetic defects, clinical presentations and treatment modalities. We present evidence from recent genetic epidemiology studies identifying disorders linked to increased CVD risk.
过时
发表于 2025-3-26 00:32:49
http://reply.papertrans.cn/59/5869/586842/586842_26.png
颠簸地移动
发表于 2025-3-26 04:21:51
Book 2015ulations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atheroscle
deadlock
发表于 2025-3-26 09:38:03
http://reply.papertrans.cn/59/5869/586842/586842_28.png
Ferritin
发表于 2025-3-26 14:14:32
The Role of Statins in Heart Failure, use unless there is an existing comorbidity. This chapter seeks to review the literature and data regarding the possible harmful and beneficial effects of statins in heart failure, the outcomes data, and future directions for research and clinical practice.
Detoxification
发表于 2025-3-26 19:45:13
Basics in Lipoprotein Metabolism,bolism. The main mechanisms of how cells metabolize and excrete cholesterol are then discussed given its relevance to atherosclerosis. Throughout the chapter, we emphasize the critical steps in lipoprotein metabolism that have been targeted by therapies, and the key pathways whose aberrations predispose to increased cardiovascular disease risk.